Experience with clinical trials of the new anti-influenza drug rimantadine
Zlydnikov, D.M.
Vrachebnoe Delo 4: 15-18
1981
ISSN/ISBN: 0049-6804 PMID: 7269469 Document Number: 169104
Document emailed within 1 workday
Related Documents
Zlydnikov, D.M. 1980: Prevention of pneumonia in influenza A by means of a new anti-influenza drug rimantadine Terapevticheskii Arkhiv 52(3): 68-71Nau, J.-Y. 2006: Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine Revue Medicale Suisse 2(50): 308
Pyhälä, R. 1993: Amantadine, rimantadine and influenza Duodecim; Laaketieteellinen Aikakauskirja 109(19): 1617-1619
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Zlydnikov, D.M.; Kubar', O.I.; Kovaleva, T.P. 1981: Chemoprophylaxis and chemotherapy of influenza with rimantadine Voprosy Virusologii 5: 516-524
Hall, C.B.; Dolin, R.; Gala, C.L.; Markovitz, D.M.; Zhang, Y.Q.; Madore, P.H.; Disney, F.A.; Talpey, W.B.; Green, J.L.; Francis, A.B. 1987: Children with influenza a infection: treatment with rimantadine Pediatrics 80(2): 275-282
Galegov, G.A.; Pushkarskaia, N.L.; Smirnova, N.R.; L'vov, N.D.; Iatsyna, A.A. 1979: Rimantadine as an inhibitor of influenza virus A/675/77 (H1N1) reproduction Voprosy Virusologii 3: 306-308
Boreko, E.I.; Pavlova, N.I.; Votiakov, V.I. 1999: Change in the sensitivity of influenza virus, replicating in the presence of rimantadine, to antiviral agents Voprosy Virusologii 44(3): 115-119
Randall, P.S. 1990: Anti-HIV drug available in trials Postgraduate Medicine 88(7): 23
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Bergmann, J.F.; Lagier, G.; Calvo, F.; Chazelle, F.; Caulin, C. 1988: Independent controls of quality in therapeutic trials. Apropos of an experience of 11 external audits of clinical investigators performed in 2 European multicenter trials Therapie 43(5): 379-384
Fraser, I.S.; Zeun, S.; Parke, S.; Wilke, B.; Junge, W.; Serrani, M. 2013: Improving the objective quality of large-scale clinical trials for women with heavy menstrual bleeding: experience from 2 multi-center, randomized trials Reproductive Sciences 20(7): 745-754
Tokimatsu, I.; Nasu, M. 2000: Anti-influenza a viral drug--amantadine Nihon Rinsho. Japanese Journal of Clinical Medicine 58(11): 2288-2292
Závadová, H.; Vonka, V.; Stárek, M.; Domorázková, E.; Bruj, J.; Skocil, V. 1975: Experience with Czechoslovak subunit anti-influenza vaccine Casopis Lekaru Ceskych 114(47): 1462-1466
Gleiter, C.H.; Bieck, P.R. 1991: Clinical drug trials. 1: the 4 phases of clinical trials Fortschritte der Medizin 109(5): 136-137
Kiso, M.; Kawaoka, Y. 2012: Anti-influenza drug--current status and future prospects Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 574-578
Sjöqvist, F. 1980: The measurement of psychotherapeutic drug concentrations in biological fluids: utility in clinical trials and practice. Overview by drug classes--clinical monitoring of tricyclic antidepressant plasma concentrations Psychopharmacology Bulletin 16(3): 21-25
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Talwar, G.P.; Singh, O.; Pal, R.; Chatterjee, N. 1992: Anti-hCG vaccines are in clinical trials Scandinavian Journal of Immunology. Suppl 11: 123-126